SAN DIEGO–()–Invivoscribe is pleased to announce that on June 5th the Ministry of Health, Labor and Welfare (MHLW) approved our LeukoStrat® CDx FLT3 Mutation Assay as the companion diagnostic for…
Originalartikel lesen: …in EDTA – Business Wire China